Strongly consider starting a second-line agent with metformin at diagnosis if the patient's HbA1c > 8%, as most of these will not reach an HbA1c target <7% with metformin alone.

Formal Recommendations

Recommendation & Evidence

Recommendation StrengthNone
Evidence LevelNone

Categories

Glycaemic targetsTreatment initiation, intensification, and adjustmentMetformin
Recommendation No.: 2-2024-035E-024R Guideline No.: 2-2024-035EGuideline: Samoa MOH National Diabetes Guidelines

PICO Question

P

Population

People newly diagnosed with type 2 diabetes and HbA1c >8%

I

Intervention

Start a second-line glucose-lowering agent together with metformin at diagnosis

C

Comparison

Metformin alone

O

Outcome

Achievement of HbA1c target <7%

Evidence Information

Evidence No.-
Evidence-
Evidence LevelNone
Recommendation StrengthNone
Statement TypeFormal Recommendations

Guideline Information

Guideline NameSamoa MOH National Diabetes Guidelines
Guideline No.2-2024-035E
AuthorAlec Ekeroma
Guideline TypeGuideline
Year2024
OrganizationMinistry of Health Samoa
RegionOceania
CountrySamoa
Conflict of InterestNo
DOI
Target Population所有糖尿病患者(包括1型糖尿病、2型糖尿病、妊娠期糖尿病、儿童及青少年),特别是萨摩亚及太平洋人群,包括高危人群(超重/肥胖、有家族史、既往糖尿病史等)
Journal
Recommendation Strength Methodology
Evidence Level Methodology

Other Information

Living GuidelineNo
Rapid AdviceNo
UpdatedNo
Recommendation Count0
Reference Count50
Guideline TopicComprehensive
CategoriesGlycaemic targets, Treatment initiation, intensification, and adjustment, Metformin
Created At2026-07-28 17:47:18
Updated At2026-07-28 17:47:18